Reference27 articles.
1. Organization for Economic Cooperation and Development, Health Care Systems in Transition: The Search for Efficiency, Paris: OECD, 1990.
2. Peltzman S, “An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments,” Journal of Political Economy 8:1049–1091, 1973.
3. Wiggins SN, “Product Availability Regulation and New Drug Introductions: Some New Evidence from the 1970s,” Review of Economics and Statistics 63:615–619, 1981.
4. Thomas LG, “Regulation and Firm Size: FDA Impacts on Innovation,” RAND Journal of Economics 21:4(497–517), Winter 1990.
5. Grabowski HG, Vernon JM, and Thomas LG, “Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry,” Journal of Law and Economics 2:133–163, 1978.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献